NCT03684018 - Two Dose Levels of Privigen in Pediatric CIDP | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

December 20, 2029

Study Completion Date

December 20, 2029

Conditions

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Interventions

BIOLOGICAL

IgPro10

Normal human immunoglobulin G administered intravenously

Trial Locations (9)

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

COMPLETED

Children's Specialty Group, Norfolk

WITHDRAWN

Le Bonheur Children's Hospital, Memphis

WITHDRAWN

Akron Children's Hospital, Akron

RECRUITING

Neurology Rare Disease Center, Denton

COMPLETED

Phoenix Children's Hospital, Phoenix

WITHDRAWN

Children's Hospital of Los Angeles, Los Angeles

RECRUITING

Seattle Children's Hospital, Seattle

WITHDRAWN

University of Iowa Hospitals and Clinics, Iowa City